Zai Lab Gross Profit 2016-2022 | ZLAB
Zai Lab gross profit from 2016 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Zai Lab Annual Gross Profit (Millions of US $) |
2021 |
$92 |
2020 |
$32 |
2019 |
$9 |
2018 |
$0 |
2017 |
$ |
2016 |
$ |
2015 |
$ |
Zai Lab Quarterly Gross Profit (Millions of US $) |
2022-03-31 |
$31 |
2021-12-31 |
$22 |
2021-09-30 |
$31 |
2021-06-30 |
$26 |
2021-03-31 |
$13 |
2020-12-31 |
$8 |
2020-09-30 |
$10 |
2020-06-30 |
|
2020-03-31 |
$6 |
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2018-12-31 |
|
2017-12-31 |
|
2017-06-30 |
|
2016-12-31 |
|
2015-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$3.334B |
$0.144B |
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
|